Auto saved by Logseq

master
Borja Robert 11 months ago
parent 1ad84b45d3
commit 941b5caeb5

@ -86,5 +86,5 @@
- ### Background
- Especificar que la novel formulation es una fixed-dose coformulation de [[Ivermectina]] y [[Albendazol]].
- Especificar que esta fixed-dose coformulation de ivm/alb has the lowest [[level]] of investment risk of all candidates for Combinations for [[STH]] treatment (fuente: Soil Transmitted Helminths Drug Combinations Expert Meeting, 2016, Gates Foundation)
- El ALIVE trial protocol: https://gatesopenresearch.org/articles/6-62/v1
- Una referencia específica : https://gatesopenresearch.org/articles/6-62/v1
-
Loading…
Cancel
Save